Want to see GB:GELN full AI Analyst Report?
GELN Stock Chart & Stats
18.50 p
1.00 p(6.25%)
At close: 4:00 PM EST
18.50 p
1.00 p(6.25%)
Day’s Range― - ―
52-Week Range12.00 p - 30.00 p
Previous CloseN/A
Volume5.00K
Average Volume (3M)395.75K
Market Cap
£41.30M
Enterprise Value21.39M
Total Cash (Recent Filing)£10.52M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.15
Next Earnings
Nov 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding229,421,460
10 Day Avg. Volume121,404
30 Day Avg. Volume395,753
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)3.53
Price to Sales (P/S)38.63
P/FCF Ratio-7.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)£11.50M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetExtremely low debt provides durable solvency and financial flexibility while Gelion continues R&D and scale-up. A conservatively levered balance sheet reduces short-term refinancing risk and supports staged investment in commercialization over the next 2–6 months.
Third-Party Prototyping ValidationIndependent prototyping by reputable partners (TDK, QinetiQ) materially de-risks core chemistry and cell assembly steps. External validation improves chances of commercial integration and long-term adoption versus in-house proof only, strengthening commercialization prospects.
Material Scale-Up And Non-Dilutive FundingAchieving a commercial-target CAM scale and securing increased grant funding demonstrates tangible manufacturing progress and lowers the incremental capital needed to reach demo scale. This combination supports durable operational progress toward revenue generation.
Bears Say
Persistent Negative Cash FlowSustained negative operating and free cash flows indicate ongoing cash burn and reliance on external funding. Absent rapid commercialization or material non-dilutive grants, cash flow weakness constrains runway, limits strategic optionality, and heightens dilution risk over the medium term.
Very Small, Volatile Revenue And Deep LossesMinimal and volatile sales alongside large negative margins show the business remains pre-commercial. Without sustainable, growing integration or product revenues, unit economics and scalability remain unproven, making profitability and self-funding unlikely within the near term.
Technical And Partner Execution RisksOngoing yield improvements, full-cell calendar life validation, and partner transitions (e.g., Ionblox disruption noted elsewhere) are material execution hurdles. These technical and partner risks can delay commercialization, inflate costs, and impede scaling of reliable manufacturing economics.
Gelion PLC News
GELN FAQ
What was Gelion PLC’s price range in the past 12 months?
Gelion PLC lowest share price was 12.00 p and its highest was 30.00 p in the past 12 months.
What is Gelion PLC’s market cap?
Gelion PLC’s market cap is £41.30M.
When is Gelion PLC’s upcoming earnings report date?
Gelion PLC’s upcoming earnings report date is Nov 11, 2026 which is in 113 days.
How were Gelion PLC’s earnings last quarter?
Gelion PLC released its earnings results on Mar 02, 2026. The company reported -0.017 p earnings per share for the quarter, missing the consensus estimate of N/A by -0.017 p.
Is Gelion PLC overvalued?
According to Wall Street analysts Gelion PLC’s price is currently Overvalued.
Does Gelion PLC pay dividends?
Gelion PLC does not currently pay dividends.
What is Gelion PLC’s EPS estimate?
Gelion PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Gelion PLC have?
Gelion PLC has 229,421,460 shares outstanding.
What happened to Gelion PLC’s price movement after its last earnings report?
Gelion PLC reported an EPS of -0.017 p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 8.333%.
Which hedge fund is a major shareholder of Gelion PLC?
Currently, no hedge funds are holding shares in GB:GELN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Gelion PLC Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
1.31%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
59.13%
Trailing 12-Months
Company Description
Gelion PLC
Gelion plc, founded in 2015 and headquartered in Eveleigh, Australia, specializes in the comprehensive process of battery systems. This includes their investigation, conceptualization, engineering, manufacturing, and distribution, serving clients both within the United Kingdom and internationally. The company's prominent offering is its Endure range of zinc-bromide batteries. These energy storage solutions are deployed across a broad spectrum of applications, such as powering industrial light towers, providing storage for renewable energy installations like solar and wind farms, supporting desalination efforts, operating mining pumps, electrifying various modes of transport including passenger vehicles, heavy-duty trucks, electric buses, and trains, and fulfilling requirements for irrigation and other agricultural tasks. Additionally, their products are utilized by commercial and industrial entities, as well as by operators of electricity grids.